{"id":"https://openalex.org/W4283587767","doi":null,"title":"Liraglutide Attenuates Restenosis After Vascular Injury in Rabbits With Diabetes Via the TGF-\u03b2/Smad3 Signaling Pathway.","display_name":"Liraglutide Attenuates Restenosis After Vascular Injury in Rabbits With Diabetes Via the TGF-\u03b2/Smad3 Signaling Pathway.","alternate_titles":[],"publication_year":2022,"publication_date":"2022-09-01","ids":{"openalex":"https://openalex.org/W4283587767","pmid":"https://pubmed.ncbi.nlm.nih.gov/35751893"},"language":"en","primary_location":{"id":"pmid:35751893","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35751893","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alternative therapies in health and medicine","raw_type":"Journal Article"},"parent_works":[],"lineage":["https://openalex.org/W4283587767"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103439410","display_name":"Haixia Ding","orcid":"https://orcid.org/0000-0001-6345-1448","observed_orcids":["https://orcid.org/0000-0001-6345-1448"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hai-Xia Ding","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038021123","display_name":"Nan-Xi Dong","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Nan-Xi Dong","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101511369","display_name":"Chaoxi Zhou","orcid":"https://orcid.org/0000-0001-6933-5309","observed_orcids":["https://orcid.org/0000-0001-6933-5309"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Chao-Xi Zhou","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100717598","display_name":"Fujun Wang","orcid":"https://orcid.org/0000-0002-2851-6709","observed_orcids":["https://orcid.org/0000-0002-2851-6709"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Fu-Jun Wang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101758353","display_name":"Na Xing","orcid":"https://orcid.org/0000-0003-2638-9045","observed_orcids":["https://orcid.org/0000-0003-2638-9045"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Na Xing","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100570046","display_name":"Hongfang Ma","orcid":"https://orcid.org/0009-0004-6652-6299","observed_orcids":["https://orcid.org/0009-0004-6652-6299"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hong-Fang Ma","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5100527909","display_name":"Lin Hou","orcid":"https://orcid.org/0009-0000-6373-9433","observed_orcids":["https://orcid.org/0009-0000-6373-9433"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Lin Hou","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.8,"has_fulltext":false,"cited_by_count":12,"citation_normalized_percentile":{"value":0.64272349,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":95,"max":97},"biblio":{"volume":"28","issue":"6","first_page":"22","last_page":"28"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11501","display_name":"TGF-\u03b2 signaling in diseases","score":0.45649999380111694,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11501","display_name":"TGF-\u03b2 signaling in diseases","score":0.45649999380111694,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10155","display_name":"Nitric Oxide and Endothelin Effects","score":0.11110000312328339,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.09059999883174896,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/restenosis","display_name":"restenosis","score":0.7480000257492065},{"id":"https://openalex.org/keywords/neointimal-hyperplasia","display_name":"intimal hyperplasia","score":0.9070000052452087},{"id":"https://openalex.org/keywords/diabetes-mellitus","display_name":"diabetes mellitus","score":0.9309999942779541},{"id":"https://openalex.org/keywords/tgf-beta1-smad3-signaling-pathway","display_name":"TGF-\u03b21/Smad3 signaling","score":0.9259999990463257},{"id":"https://openalex.org/keywords/lower-limb-ischemia","display_name":"lower limb ischemia","score":0.8190000057220459},{"id":"https://openalex.org/keywords/vascular-injury","display_name":"vascular injury","score":0.6039999723434448},{"id":"https://openalex.org/keywords/epithelial-mesenchymal-transition","display_name":"epithelial-mesenchymal transition","score":0.8889999985694885},{"id":"https://openalex.org/keywords/vascular-smooth-muscle-cells","display_name":"vascular smooth muscle cells","score":0.8009999990463257},{"id":"https://openalex.org/keywords/oxidative-stress","display_name":"oxidative stress","score":0.7670000195503235},{"id":"https://openalex.org/keywords/reactive-oxygen-species","display_name":"reactive oxygen species","score":0.6570000052452087},{"id":"https://openalex.org/keywords/collagen-synthesis","display_name":"collagen synthesis","score":0.4230000078678131},{"id":"https://openalex.org/keywords/e-cadherin","display_name":"E-cadherin","score":0.7519999742507935},{"id":"https://openalex.org/keywords/mmp-9","display_name":"MMP-9","score":0.9860000014305115},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.7400000095367432}],"concepts":[{"id":"https://openalex.org/C2781308992","wikidata":"https://www.wikidata.org/wiki/Q2526479","display_name":"Liraglutide","level":4,"score":0.8631168007850647},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6259453296661377},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6047345399856567},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.5913608074188232},{"id":"https://openalex.org/C2778095995","wikidata":"https://www.wikidata.org/wiki/Q17147174","display_name":"Neointimal hyperplasia","level":4,"score":0.5803780555725098},{"id":"https://openalex.org/C2779751240","wikidata":"https://www.wikidata.org/wiki/Q16909635","display_name":"Intimal hyperplasia","level":3,"score":0.5604953169822693},{"id":"https://openalex.org/C2778760513","wikidata":"https://www.wikidata.org/wiki/Q24773045","display_name":"Glutathione peroxidase","level":4,"score":0.486608624458313},{"id":"https://openalex.org/C2779280383","wikidata":"https://www.wikidata.org/wiki/Q257331","display_name":"Streptozotocin","level":3,"score":0.4629986882209778},{"id":"https://openalex.org/C2778401633","wikidata":"https://www.wikidata.org/wiki/Q418661","display_name":"Malondialdehyde","level":3,"score":0.41889864206314087},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.41546106338500977},{"id":"https://openalex.org/C2775838275","wikidata":"https://www.wikidata.org/wiki/Q410776","display_name":"Superoxide dismutase","level":3,"score":0.40995141863822937},{"id":"https://openalex.org/C2778283817","wikidata":"https://www.wikidata.org/wiki/Q6590597","display_name":"Restenosis","level":3,"score":0.3248971104621887},{"id":"https://openalex.org/C2776151105","wikidata":"https://www.wikidata.org/wiki/Q898814","display_name":"Oxidative stress","level":2,"score":0.27234911918640137},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.08238312602043152},{"id":"https://openalex.org/C2778583881","wikidata":"https://www.wikidata.org/wiki/Q1325542","display_name":"Stent","level":2,"score":0.0},{"id":"https://openalex.org/C2992686903","wikidata":"https://www.wikidata.org/wiki/Q208453","display_name":"Smooth muscle","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000069450","descriptor_name":"Liraglutide","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000069450","descriptor_name":"Liraglutide","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000975","descriptor_name":"Antioxidants","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D003251","descriptor_name":"Constriction, Pathologic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003920","descriptor_name":"Diabetes Mellitus","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006943","descriptor_name":"Hyperglycemia","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006965","descriptor_name":"Hyperplasia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D011817","descriptor_name":"Rabbits","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013482","descriptor_name":"Superoxide Dismutase","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015398","descriptor_name":"Signal Transduction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015820","descriptor_name":"Cadherins","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D017382","descriptor_name":"Reactive Oxygen Species","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D018809","descriptor_name":"Proliferating Cell Nuclear Antigen","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018809","descriptor_name":"Proliferating Cell Nuclear Antigen","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D020780","descriptor_name":"Matrix Metalloproteinase 9","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D020780","descriptor_name":"Matrix Metalloproteinase 9","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D024042","descriptor_name":"Collagen Type I","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D053773","descriptor_name":"Transforming Growth Factor beta1","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D053773","descriptor_name":"Transforming Growth Factor beta1","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D057772","descriptor_name":"Vascular System Injuries","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":1,"locations":[{"id":"pmid:35751893","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35751893","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alternative therapies in health and medicine","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4283314024","https://openalex.org/W4225130266","https://openalex.org/W4281681516","https://openalex.org/W2950515961","https://openalex.org/W3031761874","https://openalex.org/W3011611483","https://openalex.org/W7118220359","https://openalex.org/W4411293167","https://openalex.org/W2760658785","https://openalex.org/W4318590267"],"abstract_inverted_index":{"Background:":[0],"Lower":[1],"limb":[2,91,224,402],"ischemia":[3,92,225,403],"due":[4],"to":[5,43,54,114,161,173,183,189,197],"arterial":[6],"stenosis":[7],"is":[8,19,41],"a":[9,20,24,59,89,101],"major":[10],"complication":[11],"in":[12,36,70,138,200,226,252],"patients":[13,37],"with":[14,38,74,82,287],"diabetes":[15],"mellitus":[16],"(DM).":[17],"Liraglutide":[18,236,310,341,373],"long-acting":[21],"analogue":[22],"of":[23,50,123,140,203,212,256,345],"glucagon-like":[25],"peptide":[26],"1":[27,316],"(GLP-1)":[28],"receptor":[29],"agonist":[30],"used":[31,113,172,196],"for":[32],"lowering":[33],"blood":[34,63],"glucose":[35],"DM,":[39],"and":[40,65,76,88,106,129,134,143,179,192,205,231,246,273,305,307,336,338,384,394,398,404],"believed":[42],"possess":[44],"cardiovascular":[45],"protective":[46,60],"effects.":[47],"The":[48,96,210,254,292],"aim":[49],"this":[51,361],"study":[52],"was":[53,94,112,159,171,195,219],"investigate":[55],"whether":[56],"liraglutide":[57,107,232,284,296,328],"has":[58],"effect":[61,362],"on":[62],"vessels":[64],"alleviates":[66],"vascular":[67,153,302,381],"intimal":[68,117,217,405],"hyperplasia":[69,218],"streptozotocin":[71],"(STZ)-induced":[72],"rabbits":[73,227],"DM":[75,83,289],"its":[77],"molecular":[78],"mechanism.":[79],"Methods:":[80],"Rabbits":[81],"were":[84,98,280],"induced":[85],"by":[86,147,366],"STZ,":[87],"lower":[90,223,401],"model":[93,158],"established.":[95],"animals":[97],"divided":[99],"into":[100],"control":[102],"group,":[103],"DM-injury":[104],"group":[105],"treatment":[108,233,237,285],"group.":[109,291],"Pathological":[110],"staining":[111,214],"observe":[115],"the":[116,120,136,201,288,343,356,387,392],"growth,":[118],"analyze":[119,135,162,174,184,190,198],"oxidation":[121],"levels":[122,251,279],"malondialdehyde":[124],"(MDA),":[125],"superoxide":[126],"dismutase":[127],"(SOD)":[128],"plasma":[130],"glutathione":[131],"peroxidase":[132],"(GSH-Px),":[133],"changes":[137,199],"expression":[139,202,278,344],"marker":[141,204],"proteins":[142,146],"signaling":[144,206,318,358,389],"pathway":[145,207,319],"Western":[148,193,257],"blotting.":[149],"A":[150],"hyperglycemia":[151],"(HG)-injured":[152],"smooth":[154],"muscle":[155],"cells":[156],"(VSMCs)":[157],"established":[160],"reactive":[163],"oxygen":[164],"species":[165],"(ROS)":[166],"levels,":[167,332],"Cell-Counting":[168],"Kit-8":[169],"(CCK-8)":[170],"cell":[175,185,269,303,334,382],"proliferation,":[176],"scratch":[177],"assay":[178],"Transwell":[180],"Migration":[181],"Assay":[182],"migration,":[186],"flow":[187],"cytometry":[188],"apoptosis":[191],"blotting":[194,258],"proteins.":[208],"Results:":[209],"results":[211,255,293],"pathological":[213],"showed":[215,260],"that":[216,261,295,327],"severe":[220],"after":[221,283],"diabetes-induced":[222],"at":[228],"4":[229],"weeks,":[230],"reduced":[234],"symptoms.":[235],"significantly":[238,281,375],"decreased":[239,282],"MDA":[240],"content,":[241,245],"increased":[242],"SOD,":[243],"GSH-Px":[244],"augmented":[247],"total":[248],"antioxidant":[249,378],"capacity":[250],"tissues.":[253],"analysis":[259],"E-cadherin,":[262,346],"mitochondrial":[263],"membrane":[264],"potential":[265],"9":[266],"(MMP-9),":[267],"proliferating":[268],"nuclear":[270],"antigen":[271],"(PCNA),":[272],"type":[274,349],"I":[275,350],"collagen":[276,308,351,395],"protein":[277,320,352],"compared":[286],"injury":[290],"indicated":[294],"inhibited":[297],"epithelial-mesenchymal":[298],"transition":[299],"(EMT)":[300],"progression,":[301],"proliferation":[304,335,383],"migration":[306,337,385],"production.":[309],"inhibits":[311,333],"transforming":[312],"growth":[313],"factor":[314,369],"beta":[315],"(TGF-\u03b21)/Smad3":[317],"expression.":[321],"In":[322],"vitro":[323],"assays":[324],"have":[325],"shown":[326],"reduces":[329],"cellular":[330],"ROS":[331],"promotes":[339],"apoptosis.":[340],"down-regulated":[342],"MMP-9,":[347],"PCNA,":[348],"as":[353,355],"well":[354],"TGF-\u03b21/Smad3":[357,388],"pathway,":[359,390],"but":[360],"could":[363],"be":[364],"reversed":[365],"tumor":[367],"necrosis":[368],"alpha":[370],"(TNF-\u03b1).":[371],"Conclusion:":[372],"can":[374],"improve":[376],"tissue":[377],"capacity,":[379],"reduce":[380],"via":[386],"inhibit":[391],"EMT":[393],"production":[396],"processes,":[397],"alleviate":[399],"hyperglycemia(HG)-induced":[400],"hyperplasia.":[406]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4283587767","counts_by_year":[{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":5}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2022-06-28T00:00:00"}
